# Personalized Cancer Stem Cell High-Throughput Drug Screening for Glioblastoma

> **NCT05380349** · EARLY_PHASE1 · RECRUITING · sponsor: **Swedish Medical Center** · enrollment: 10 (estimated)

## Conditions studied

- Newly Diagnosed Glioblastoma

## Interventions

- **DRUG:** combinations of up to 3 FDA approved drugs from a panel of compounds

## Key facts

- **NCT ID:** NCT05380349
- **Lead sponsor:** Swedish Medical Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-04-19
- **Primary completion:** 2026-12
- **Final completion:** 2027-12
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2025-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05380349

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05380349, "Personalized Cancer Stem Cell High-Throughput Drug Screening for Glioblastoma". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT05380349. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*